Our top pick for
HEXO Corp is a drug manufacturers—specialty & generic business based in the US. HEXO shares (HEXO) are listed on the NYSE and all prices are listed in US Dollars.
Since the stock market crash in March caused by coronavirus, HEXO's share price has had significant negative movement.
Its last market close was USD$0.742, which is 47.38% down on its pre-crash value of USD$1.41 and 114.45% up on the lowest point reached during the March crash when the shares fell as low as USD$0.346.
If you had bought USD$1,000 worth of HEXO shares at the start of February 2020, those shares would have been worth USD$492.97 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$579.69.
|Latest market close||USD$0.742|
|52-week range||USD$0.346 - USD$2.3|
|50-day moving average||USD$0.7411|
|200-day moving average||USD$0.7224|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-1.5794|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-24)||2.06%|
|1 month (2020-10-30)||22.04%|
|3 months (2020-09-01)||6.00%|
|6 months (2020-06-01)||7.54%|
|1 year (2019-11-29)||-65.65%|
|2 years (2018-11-30)||-83.73%|
|3 years (2017-12-01)||-62.31%|
|5 years (2015-11-27)||N/A|
|Gross profit TTM||USD$-57,975,000|
|Return on assets TTM||-13.4%|
|Return on equity TTM||-81.24%|
|Market capitalisation||USD$379.3 million|
TTM: trailing 12 months
There are currently 14.8 million HEXO shares held short by investors – that's known as HEXO's "short interest". This figure is 1.5% up from 14.6 million last month.
There are a few different ways that this level of interest in shorting HEXO shares can be evaluated.
HEXO's "short interest ratio" (SIR) is the quantity of HEXO shares currently shorted divided by the average quantity of HEXO shares traded daily (recently around 14.5 million). HEXO's SIR currently stands at 1.02. In other words for every 100,000 HEXO shares traded daily on the market, roughly 1020 shares are currently held short.
However HEXO's short interest can also be evaluated against the total number of HEXO shares, or, against the total number of tradable HEXO shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HEXO's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 HEXO shares in existence, roughly 30 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable HEXO shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against HEXO.
Find out more about how you can short HEXO stock.
We're not expecting HEXO to pay a dividend over the next 12 months.
Over the last 12 months, HEXO's shares have ranged in value from as little as $0.346 up to $2.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while HEXO's is 1.6952. This would suggest that HEXO's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.
Steps to owning and managing CCF, with 24-hour and historical pricing before you buy.
Steps to owning and managing CDW, with 24-hour and historical pricing before you buy.
Steps to owning and managing CWH, with 24-hour and historical pricing before you buy.
Steps to owning and managing CBIO, with 24-hour and historical pricing before you buy.
Steps to owning and managing BLIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing CVGW, with 24-hour and historical pricing before you buy.
Steps to owning and managing AEGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing AJG, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABB, with 24-hour and historical pricing before you buy.
Steps to owning and managing YGYI, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.